562 related articles for article (PubMed ID: 28223793)
1. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
[TBL] [Abstract][Full Text] [Related]
2. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD.
Gruenberger JB; Vietri J; Keininger DL; Mahler DA
Int J Chron Obstruct Pulmon Dis; 2017; 12():937-944. PubMed ID: 28360517
[TBL] [Abstract][Full Text] [Related]
3. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
[TBL] [Abstract][Full Text] [Related]
4. The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD.
Muñoz A; Small M; Wood R; Ribera A; Nuevo J
Int J Chron Obstruct Pulmon Dis; 2018; 13():1557-1568. PubMed ID: 29805254
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic burden of COPD for patients receiving dual or triple therapy.
Chen S; Small M; Lindner L; Xu X
Int J Chron Obstruct Pulmon Dis; 2018; 13():1365-1376. PubMed ID: 29731624
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
Ding B; Small M; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
[TBL] [Abstract][Full Text] [Related]
7. Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.
Müllerová H; Landis SH; Aisanov Z; Davis KJ; Ichinose M; Mannino DM; Maskell J; Menezes AM; van der Molen T; Oh YM; Tabberer M; Han MK
Int J Chron Obstruct Pulmon Dis; 2016; 11():881-90. PubMed ID: 27217741
[TBL] [Abstract][Full Text] [Related]
8. Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys.
Ding B; DiBonaventura M; Karlsson N; Ling X
Int J Chron Obstruct Pulmon Dis; 2016; 11():1139-50. PubMed ID: 27354777
[TBL] [Abstract][Full Text] [Related]
9. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.
Punekar YS; Naya I; Small M; Holbrook T; Wood R; Mullerova H; Valle M
J Med Econ; 2017 Jan; 20(1):28-36. PubMed ID: 27564685
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
[TBL] [Abstract][Full Text] [Related]
12. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries.
Kingsbury SR; Gross HJ; Isherwood G; Conaghan PG
Rheumatology (Oxford); 2014 May; 53(5):937-47. PubMed ID: 24489012
[TBL] [Abstract][Full Text] [Related]
13. Burden of peripheral arterial disease in Europe and the United States: a patient survey.
Marrett E; DiBonaventura Md; Zhang Q
Health Qual Life Outcomes; 2013 Oct; 11():175. PubMed ID: 24148832
[TBL] [Abstract][Full Text] [Related]
14. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
[TBL] [Abstract][Full Text] [Related]
15. The Association between Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Healthcare Resource Use.
DiBonaventura M; Richard L; Kumar M; Forsythe A; Flores NM; Moline M
PLoS One; 2015; 10(10):e0137117. PubMed ID: 26426805
[TBL] [Abstract][Full Text] [Related]
16. The burden of chronic obstructive pulmonary disease among employed adults.
DiBonaventura Md; Paulose-Ram R; Su J; McDonald M; Zou KH; Wagner JS; Shah H
Int J Chron Obstruct Pulmon Dis; 2012; 7():211-9. PubMed ID: 22500121
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.
Stephenson JJ; Wertz D; Gu T; Patel J; Dalal AA
Int J Chron Obstruct Pulmon Dis; 2017; 12():1947-1959. PubMed ID: 28740375
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
[TBL] [Abstract][Full Text] [Related]
19. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
[TBL] [Abstract][Full Text] [Related]
20. Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use: A Cross-Sectional Analysis of National Survey Data.
Dhamane AD; Witt EA; Su J
J Occup Environ Med; 2016 Jun; 58(6):e191-7. PubMed ID: 27206123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
